View Information Collection Request (ICR) Package

OMB Control No: 0920-1054	ICR Reference No: 201711-0920-004
Status: Historical Active	Previous ICR Reference No: 201411-0920-013
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-1054
Title: Drug Overdose Response Investigation (DORI) Data Collections
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 01/29/2018
	Date Received in OIRA: 12/14/2017
Terms of Clearance: For any Gen ICs with statistical methods, a Part B will be submitted for review along with the Gen IC and template.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	01/31/2021	36 Months From Approved	03/31/2018
Responses	6,000	0	8,100
Time Burden (Hours)	3,000	0	4,050
Cost Burden (Dollars)	0	0	0

Abstract: State and local health authorities frequently call upon CDC's National Center for Injury Prevention and Control (NCIPC) to assist in their response to urgent public health problems resulting from drug use, misuse, abuse, and overdose. When called, NCIPC supports the states and local health authorities by conducting Drug Overdose Response Investigations (DORI), which entails a rapid and flexible epidemiological response. Urgent requests such as DORIs depend on the time and resources available, number of persons involved, and other circumstances unique to the urgent conditions at hand and usually involve the development of procedures, specific data collection instruments, and the collection of critical data. This request is for a new generic approval to conduct information collections during DORIs. A three-year clearance is requested to ensure: (1) rapid deployment data collection tools and (2) timely information collection of vital information. Of particular interest is response to increasing trends in, or changing characteristics of, overdose from prescription drugs (with a special interest in opioid analgesics such as oxycodone or methadone; benzodiazepines such as alprazolam) and/or illicit drugs (e.g., heroin). Specifically, this request covers investigative collections with the following aims: (1) To understand sudden increases in drug use and misuse associated with fatal and nonfatal overdoses; (2) to understand the drivers and risk factors associated with those trends; and (3) to identify the groups most affected. This will allow CDC to effectively advise states on recommended actions to control local epidemics. Thus, the ultimate goals of these collections are to minimize adverse health consequences, provide epidemiological data collection support to the states and, based on the findings from the investigation, appropriately assist with implementation of prevention and control measures. This submission is being made to extend the approval period for three additional years.

Authorizing Statute(s): US Code: 42 USC 241 Name of Law: Public Heath Service Act

Citations for New Statutory Requirements: None

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	82 FR 32705	07/17/2017
30-day Notice:	Federal Register Citation:	Citation Date:
	82 FR 58608	12/13/2017
Did the Agency receive public comments on this ICR? Yes

Number of Information Collection (IC) in this ICR: 0

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion
Annual Number of Responses	6,000	8,100	-2,100
Annual Time Burden (Hours)	3,000	4,050	-1,050
Annual Cost Burden (Dollars)	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: Submission of 0920-1054 is an Extension of the Generic mechanism - Drug Overdose Response Investigation (DORI).

Annual Cost to Federal Government: $74,740

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

Agency Contact: Jeffrey Zirger 404 639-7118 wtj5@cdc.gov

View Generic ICR - OIRA Conclusion